Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 9
2006 4
2007 3
2008 5
2010 4
2011 9
2012 6
2013 5
2014 5
2015 13
2016 16
2017 18
2018 21
2019 20
2020 9
2021 17
2022 5
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
2018 ESC/ESH Guidelines for the management of arterial hypertension.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. Williams B, et al. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Eur Heart J. 2018. PMID: 30165516 Free article. No abstract available.
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Nontraditional systems in aging research: an update.
Mikuła-Pietrasik J, Pakuła M, Markowska M, Uruski P, Szczepaniak-Chicheł L, Tykarski A, Książek K. Mikuła-Pietrasik J, et al. Among authors: tykarski a. Cell Mol Life Sci. 2021 Feb;78(4):1275-1304. doi: 10.1007/s00018-020-03658-w. Epub 2020 Oct 9. Cell Mol Life Sci. 2021. PMID: 33034696 Free PMC article. Review.
Resistant hypertension.
Tykarski A. Tykarski A. Blood Press Suppl. 2005 Dec;2:42-5. doi: 10.1080/08038020500428989. Blood Press Suppl. 2005. PMID: 16429642 Review.
Cognitive impairment in patients after myocardial infarction.
Kasprzak D, Ganowicz-Kaatz T, Rzeźniczak J, Słomczyński M, Kaczmarek-Majer K, Budzianowski J, Pieszko K, Hiczkiewicz J, Tykarski A, Burchardt P. Kasprzak D, et al. Among authors: tykarski a. Kardiol Pol. 2023;81(5):505-507. doi: 10.33963/KP.a2023.0056. Epub 2023 Mar 5. Kardiol Pol. 2023. PMID: 36871300 Free article. No abstract available.
177 results